The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression
Open accessAbstract
Oncogene-induced senescence causes hepatocytes to secrete cytokines, which induce their immune-mediated clearance to prevent tumor initiation, a process termed "senescence surveillance." However, senescent hepatocytes give rise to hepatocellular carcinomas (HCCs), if the senescence program is bypassed or if senescent cells are not cleared. Here, we show context-specific roles for CCR2+ myeloid cells in liver cancer. Senescence surveillance requires the recruitment and maturation of CCR2+ myeloid cells, and CCR2 ablation caused outgrowth of HCC. In contrast, HCC cells block the maturation of recruited myeloid precursors, which, through NK cell inhibition, promote growth of murine HCC and worsen the prognosis and survival of human HCC patients. Thus, while senescent hepatocyte-secreted chemokines suppress liver cancer initiation, they may accelerate the growth of fully established HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, a senescenceassociated gene signature was identified in the peritumoural area of hepatocellular carcinomas both in mice and humans, with the presence of this signature in the latter correlating with poor overall survival 90 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [90]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“By contrast, during cancer development associated with accumulation of senescent cells, SASP can recruit immature myeloid cells to promote tumorigenesis in a paracrine manner160,161.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [161]
The cited source says what the claim attributes to it.
In the citing paper
“Further, the SASP can recruit immature immune-suppressive myeloid cells to prostate and liver tumors (Di Mitri et al., 2014; Eggert et al., 2016) and stimulate tumorigenesis by driving angiogenesis and metastasis (Coppe ´ et al., 2010).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Eggert et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“In some instances, the SASP can also have immunosuppressive functions (Di Mitri et al. 2014; Eggert et al. 2016).”
From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Eggert et al. 2016
The cited source says what the claim attributes to it.
In the citing paper
“For example, the SASP produced by preneoplastic hepatocytes recruits immature myeloid cells that inhibit NK cells, therefore contributing to HCC progression (Eggert et al. 2016).”
From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Eggert et al. 2016
The cited source says what the claim attributes to it.
In the citing paper
“p16 INK4a , p21 and a variety of SASP factors were detected in patient- derived non- malignant tissue surrounding the tumour boundaries of hepatocellular carcinoma lesions 90 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [90]
The cited source says what the claim attributes to it.
In the citing paper
“Via secretion of CCL2, hepatocytes with Nras G12V - induced senescence attracted a subset of CCR2 + myeloid cells that engaged cytotoxic NK cells, eventually blocking tumour immune surveillance 90 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [90]
In the citing paper
“in later stages the tumor cells block the maturation of the accumulated iMC which eventually promote the growth of established hepatocellular carcinoma by inhibiting NK cell functions (Eggert et al., 2016).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Eggert et al., 2016
In the citing paper
“in the initial stages, SASP mediated recruitment of immature myeloid cells (iMC) which when differentiated into macrophages clear the pre-malignant senescence cells to prevent cancer initiation.”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Eggert et al., 2016
In the citing paper
“peritumoral tissue senescence has been associated with poor survival in patients with hepatocellular carcinoma [362].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [362]
In the citing paper
“There is convergent evidence that this occurs via the recruitment of myeloid-derived suppressor cells (MDSCs) chemoattracted by factors (e.g., IL-6, IL-8, and CCL2) secreted by senescent cells in murine models of HCC, 193 prostate, 194 and skin cancers.195”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [193]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Deshmane, S. L., Kremlev, S., Amini, S., & Sawaya, B. E. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0027 · Cited by 3,889
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Self-citationA complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278 · cited 5×
“These findings have important implic which are being evaluated for the treatment of various diseases pression in patients with advanced HCC but may fuel liver can Cancer neighboring tissue and immune cells (Acosta et al., 2013; Coppe et al., 2010; Kuilman et al., 2008).”
InfluentialSelf-citationOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Self-citation
Cited by
Sorted by citations
Items 401–500 of 610
Hand, F., Harmon, C., Elliott, L., Caiazza, F., Lavelle, A., Maguire, D., Hoti, E., Nolan, N. P., Geoghegan, J., Ryan, E. J., et al. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2149-5 · Cited by 9
T cells engineered to target senescence
Wagner, V., & Gil, J. (2020) · Nature · doi:10.1038/d41586-020-01759-x · Cited by 9
Hu, X., Guo, L., Liu, G., Dai, Z., Wang, L., Zhang, J., & Wang, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.997702 · Cited by 10
Molecular Mechanisms of Senescence and Implications for the Treatment of Myeloid Malignancies
Ernst, P., & Heidel, F. H. (2021) · Cancers · doi:10.3390/cancers13040612 · Cited by 9
Fan, G., Xie, T., Tan, Q., Lou, N., Wang, S., Han, X., & Shi, Y. (2023) · iScience · doi:10.1016/j.isci.2023.107894 · Cited by 8
Wilkinson, A. L., Hulme, S., Kennedy, J. I., Mann, E. R., Horn, P., Shepherd, E. L., Yin, K., Zaki, M. Y. W., Hardisty, G. R., Lu, W., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107966 · Cited by 10
TEAD4 antagonizes cellular senescence by remodeling chromatin accessibility at enhancer regions
Zhang, D., Zhu, Y., Ju, Y., Zhang, H., Zou, X., She, S., Zhu, D., & Guan, Y. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04980-9 · Cited by 8
Celastrol mediates CAV1 to attenuate pro-tumorigenic effects of senescent cells
Zhang, S., Zhu, N., Shi, Y., Zeng, Q., Zhang, C., Li, H., & Li, Q. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155614 · Cited by 8
Identification of immunosenescence of unconventional T cells in hepatocellular carcinoma
Li, R., Li, Z., Luo, W., Zhu, X., & Luo, B. (2024) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2024.108148 · Cited by 8
Lu, X., Luo, Y., Huang, Y. L., Zhu, Z., Yin, H., & Xu, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020773 · Cited by 7
Lactylation: A Novel Epigenetic Regulator of Cellular Senescence
Sun, C., Li, J., Dong, L., Mou, Y., Zhang, B., & Song, X. (2025) · Aging and Disease · doi:10.14336/ad.2025.0277 · Cited by 8
Targeting Senescence in Oncology: An Emerging Therapeutic Avenue for Cancer
Meguro, S., Makabe, S., Yaginuma, K., Onagi, A., Tanji, R., Matsuoka, K., Hoshi, S., Koguchi, T., Kayama, E., Hata, J., et al. (2025) · Current Oncology · doi:10.3390/curroncol32080467 · Cited by 8
The Roles of Myeloid-Derived Suppressor Cells in Liver Disease
Zhang, C., Sui, Y., Liu, S., & Yang, M. J. (2024) · Biomedicines · doi:10.3390/biomedicines12020299 · Cited by 8
Human innate immune cell crosstalk induces melanoma cell senescence
Funck, F., Pahl, J. H. W., Kyjacová, L., Freund, L., Oehrl, S., Gräbe, G., Pezer, S., Hassel, J. C., Sleeman, J. P., Cerwenka, A., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1808424 · Cited by 9
Cellular Senescence: a Promising Therapeutic Target in Colorectal Cancer
Wu, Y., Xie, M., Sun, J., Li, C., Dong, G., Zhang, Q.-S., & Cui, P. (2022) · Future Oncology · doi:10.2217/fon-2021-0661 · Cited by 9
Immune therapeutic strategies for the senescent tumor microenvironment
Yasuda, T., & Wang, Y. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02865-7 · Cited by 10
Hepatic Fibrosis and Liver Cancer
Anton, A., Friedman, S. L., & Cogliati, B. (2025) · Seminars in Liver Disease · doi:10.1055/a-2779-4937 · Cited by 10
Chen, Y., Shen, J., Zhao, X., He, Q., & Zhang, J. (2024) · Immunology and Cell Biology · doi:10.1111/imcb.12812 · Cited by 7
Chen, Z., Huang, L., Ding, L., Zhang, C., Li, Y., Wang, B., Shi, J., & Zhang, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-07585-3 · Cited by 7
Targeting the stress support network regulated by autophagy and senescence for cancer treatment
Kim, J., Lee, Y., Roh, K., Kim, M.-S., & Kang, C. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.003 · Cited by 7
Xing, T., Hu, Y., Wang, H., & Zou, Q. (2023) · Medicine · doi:10.1097/md.0000000000033739 · Cited by 7
Chaib, S., Lopez-Dominguez, J. A., Lalinde-Gutiérrez, M., Prats, N., Marín, I., Meyer, K. R., Muñoz, M. I., Aguilera, M., Mateo, L., Attolini, C. S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.04.501681 · Cited by 7
Rademacher, D. J., Exline, J. E., & Foecking, E. M. (2025) · Biomedicines · doi:10.3390/biomedicines13061400 · Cited by 8
Alghamdi, E., & Kono, K. (2025) · Cancer Science · doi:10.1111/cas.70223 · Cited by 7
Wu, E., Li, X., Ni, Z., Zhao, F., & Jia, C. (2026) · Journal of Oral Microbiology · doi:10.1080/20002297.2026.2616138 · Cited by 6
Haibo, Z., Tianyun, L., Chen, X., & Xiaoyan, H. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-10690-z · Cited by 6
Targeting cellular senescence as a therapeutic vulnerability in gastric cancer
Geng, H., Huang, C., Xu, L., Zhou, Y., Dong, Z., Zhong, Y., Li, Q., Yang, C. G., Huang, S., Liao, W., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122631 · Cited by 6
Exploring the Complexity and Promise of Tumor Immunotherapy in Drug Development
Feng, Y., He, C., Liu, C., Shao, B., Wang, D., & Wu, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126444 · Cited by 6
Transcription factor network dynamics during the commitment to oncogene-induced senescence
Vasilopoulos, T., & Martínez‐Zamudio, R. I. (2024) · Frontiers in Epigenetics and Epigenomics · doi:10.3389/freae.2024.1423454 · Cited by 5
Measuring the impact of therapy-induced senescence on NK cell phenotypes in cancer
Chowdhury, S. R., Murphy, K. C., Parikh, C. N., DeMarco, K. D., Zhou, L., & Ruscetti, M. A. (2024) · Methods in cell biology · doi:10.1016/bs.mcb.2024.07.010 · Cited by 6
Duduyemi, O. P., Potapenko, K. S., Ліманська, Н. В., Kotsyuda, S. S., Petriv, N., Suo, H., Gudzenko, T., Ivanytsia, V., & Yevsa, T. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1451170 · Cited by 6
Self-citationSomatostatin in hepatocellular carcinoma: experimental and therapeutic implications
Kouroumalis, E., Samonakis, D., & Notas, G. (2018) · Hepatoma Research · doi:10.20517/2394-5079.2018.33 · Cited by 6
Luo, H., Liu, G., Jian, D., Liang, D., Li, X., Zhong, L., Yang, B. Y., Jiang, J. H., Wang, D., Li, M., et al. (2022) · Journal of Immunology Research · doi:10.1155/2022/9962397 · Cited by 6
Liu, A., Wang, X., Liu, H., Yan, D., Yin, Y., Zheng, H., Liu, G., Zhang, J., & Li, Y. (2023) · PLoS ONE · doi:10.1371/journal.pone.0287132 · Cited by 6
Self-citationImmunologic landscape of human hepatic hemangiomas and epithelioid hemangioendotheliomas
Thomann, S., Metzler, T., Tóth, M., Schirmacher, P., & Mogler, C. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000359 · Cited by 7
Proteomics Approaches to Define Senescence Heterogeneity and Chemotherapy Response
Petit, C., Guillon, J., Toutain, B., Boissard, A., Patsouris, A., Lelièvre, E., Guette, C., & Coqueret, O. (2019) · PROTEOMICS · doi:10.1002/pmic.201800447 · Cited by 5
AP-1 Imprints a Reversible Transcriptional Program of Senescent CellsPreprint
Martínez-Zamudio, R. I., Roux, P., de Freitas, J. A. N. L. F., Robinson, L. J., Doré, G. R. G., Sun, B., Gil, J., Herbig, U., & Bischof, O. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/633594 · Cited by 6
Murphy, K. C., & Ruscetti, M. A. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041348 · Cited by 7
The roles of cell cycle proteins in regulating the tumor immune microenvironment
Zhu, Q., Wei, X., Qu, Z., Lu, L., Zhang, Y., & Wang, H. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101706 · Cited by 6
Naruhn, J., Gröper, M. N., Öcal, E., Salvermoser, L., Hirner-Eppeneder, H., Schäfer, J. N., Kazmierczak, P. M., Corradini, S., Well, J., Ricke, J., et al. (2025) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2025.111068 · Cited by 5
Senescent human fibroblasts have increased FasL expression and impair the tumor immune response
Cruz-Barrera, M., Dulong, J., Nehmo, G. M., Sonn, A., Moquin‐Beaudry, G., Benabdallah, B., Lê, O., & Beausejour, C. M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1685269 · Cited by 5
Wang, H., Chen, W., Cui, Y., Gong, H., & Li, H. (2023) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v15.i9.1567 · Cited by 5
Functional screening to identify senescence regulators in cancer
Lujambio, A., & Banito, A. (2019) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2019.02.001 · Cited by 6
Pacifico, F., Crescenzi, E., & Leonardi, A. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1669-7_12 · Cited by 6
Identification of Key Functional Modules and Immunomodulatory Regulators of Hepatocellular Carcinoma
Luo, D., Zhang, X., Li, X., & Chen, G. (2021) · Journal of Immunology Research · doi:10.1155/2021/1801873 · Cited by 5
APOBEC3B: Future direction of liver cancer research
Yang, X., Dai, J., Yao, S., An, J., Wen, G., Jin, H., Zhang, L., Zheng, L., Chen, X., Yi, Z., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.996115 · Cited by 5
The mononuclear phagocyte system in hepatocellular carcinoma
Qiao, D.-R., Shan, G.-Y., Wang, S., Cheng, J.-Y., Yan, W., & Li, H.-J. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i45.6345 · Cited by 5
Ma, R., Liu, W., Sun, T., Dang, C., & Li, K. (2023) · PeerJ · doi:10.7717/peerj.15373 · Cited by 5
Senescence-related signatures predict prognosis and response to immunotherapy in colon cancer
Hu, X., Zhu, X., Chen, Y., Zhang, W., Li, L., Liang, H., Байматович, У. Б., Donadon, M., Yusupbekov, A., & Zheng, Y. (2024) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-24-339 · Cited by 5
Okamura, K., Sato, M., Suzuki, T., & Nohara, K. (2024) · Environmental Health and Preventive Medicine · doi:10.1265/ehpm.24-00139 · Cited by 5
Barley Grass Juice Attenuates Hydrodynamic Transfection-Induced HCC Initiation in Mice
Li, J., Zhang, W., Xu, H., Zhou, L., Guo, H., Zhang, S., Lu, R., Liang, X., Chang, M., & Liu, C. (2022) · Nutrition and Cancer · doi:10.1080/01635581.2022.2151633 · Cited by 5
Koziej, P., Kluszczyńska, K., Hartman, M. L., & Czyż, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097891 · Cited by 5
SOX2 drives fetal reprogramming and reversible dormancy in colorectal cancerPreprint
Baulies, A., Moncho-Amor, V., Garcia, D. D., Kucharska, A., Chakravarty, P., Moreno‐Valladares, M., Cruces‐Salguero, S., Hubl, F., Hutton, C., Kim, H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.11.612412 · Cited by 5
He, Y., Long, K., Du, B., Liao, W., Zou, R., Su, J., Luo, J., Shi, Z., & Wang, L. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150576 · Cited by 5
Senescent cancer cells in immune surveillance and evasion: mechanisms and therapeutic implications
De-chang, L., Wang, J., Wei, Y., Wu, H. Y., Yuan, S., Yang, M. J., & Sun, L. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf125 · Cited by 4
Antonangeli, F., Arcuri, E., & Santoni, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1694567 · Cited by 5
Fang, B., Pan, F., Chen, S., Tian, W., Zhu, Y., Shen, Y., Wang, H., Guo, H., Ding, Y. F., Wang, Y., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202524946 · Cited by 4
Immunosuppressive macrophages determine the effect of cellular senescence on tumor progression
Lalinde-Gutiérrez, M., Pérez‐Ramos, S., Rodilla, V., Garcia-Baucells, P., Julia, P.-B., Berenguer‐Molins, P., Nonell, L., Agustí-Barea, I., Mueller, C. G., & Arribas, J. (2026) · Science Advances · doi:10.1126/sciadv.adx2988 · Cited by 4
Ju, N., Zhao, L., Yin, S., Yang, X., Zhou, J., Gao, J., & Qi, F. (2026) · International Journal of Cancer · doi:10.1002/ijc.70442 · Cited by 4
A Conversation with ChatGPT on Contentious Issues in Senescence and Cancer Research
Elshazly, A. M., Shahin, U., Shboul, S. A., Gewirtz, D. A., & Saleh, T. (2024) · Molecular Pharmacology · doi:10.1124/molpharm.124.000871 · Cited by 4
Epithelial cell competition is promoted by signaling from immune cells
Zhu, Y., Wunderlich, Z., & Lander, A. D. (2025) · Nature Communications · doi:10.1038/s41467-025-59130-5 · Cited by 6
Qi, L., Chen, F., Wang, L., Yang, Z., Zhang, W., & Li, Z. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1229233 · Cited by 4
Ding, C., Xu, X., Zhang, X., Zhang, E., Li, S., Fan, X., Ma, J., Yang, X. Y., & Zang, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-70300-1 · Cited by 4
Yang, X., Wang, H., & Yu, C. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s484265 · Cited by 4
Wu, M., Shi, Q.-M., Duan, S.-L., Ou-yang, D.-J., Chen, P., Tu, B., & Huang, P. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s352574 · Cited by 4
Xu, D., Chen, X., Wu, M., Bi, J., Xue, H., & Chen, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28278 · Cited by 4
Implantable Highly Compliant Devices for Heating of Internal Organs: Toward Cancer Treatment
Bermúdez, G. S. C., Kruv, A., Voitsekhivska, T., Hochnadel, I., Lebanov, A., Potthoff, A., Faßbender, J., Yevsa, T., & Makarov, D. (2019) · Advanced Engineering Materials · doi:10.1002/adem.201900407 · Cited by 4
Self-citationA ganglioside-based senescence-associated immune checkpointPreprint
Iltis, C., Seguin, L., Cervera, L., Duret, L. C., Hamidouche, T., Kunz, S., Croce, O., Delannoy, C. P., Guérardel, Y., Allain, F., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.23.440408 · Cited by 4
Ghabra, S., Trehan, R., Rodríguez-Matos, F., Ma, C., & Greten, T. F. (2024) · STAR Protocols · doi:10.1016/j.xpro.2024.103341 · Cited by 3
Self-citationUnraveling senescence in cancer: mechanistic complexities and therapeutic opportunities
Tiwari, P., Shukla, S. K., & Verma, S. R. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10630-z · Cited by 3
Cellular Senescence in Cancer: Mechanisms, Roles in Tumor Progression, and Therapeutic Implications
Yan, J., Zhang, Y., Mao, G., Yu, J., Zhou, T., & Hao, J. (2025) · MedComm – Oncology · doi:10.1002/mog2.70029 · Cited by 3
Huang, G., & Li, D. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1751290 · Cited by 3
Wang, Y., Dai, L., Huang, R., Li, W., & Wu, W. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1203351 · Cited by 3
Senescence detection using reflected light
Dedic, B., Westerberg, L. J. S., Solís, A. M., Dumont, K. D., Ruas, J. L., Thorell, A., Näslund, E. B., & Spalding, K. L. (2024) · Aging Cell · doi:10.1111/acel.14295 · Cited by 2
Identification of novel inhibitors of the transcriptional coactivator MRTF-A for HCC therapy
Franz, M. J., Wenisch, P., Wohlleben, P., Rupprecht, L., Chubanov, V., Gudermann, T. W., Kyheröinen, S., Vartiainen, M. K., Heinrich, M. R., & Muehlich, S. (2024) · Molecular Therapy Oncology · doi:10.1016/j.omton.2024.200855 · Cited by 3
Missale, G., & Cariani, E. (2018) · Hepatoma Research · doi:10.20517/2394-5079.2018.72 · Cited by 3
Premalignant lesions and cellular senescence
Georgakopoulou, E. A., Evangelou, K., & Gorgoulis, V. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00001-8 · Cited by 3
Role of CXCR6 in Antitumor Immune Surveillance
Kim, T. H., & Kim, S. G. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.03.032 · Cited by 3
Ambient NO2 induces premature pulmonary senescence in rats: The role of the ROS-DRG1/CDK5 axis
Ye, S., Luo, S., Tan, Y., Zhang, R., Ji, D., & Xiao, F. (2025) · Journal of Environmental Sciences · doi:10.1016/j.jes.2025.08.058 · Cited by 2
Zhao, Y., Cong, D., Qu, C., Wang, Z., Yuan, W., & Bai, Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149215 · Cited by 2
Makulyte, G., Safwan‐Zaiter, H., Goehrig, D., Huna, A., Mangelinck, A., Mikawa, T., Palazzo, A., Moudombi, L., Médard, J., Chanal, M., et al. (2025) · Aging Cell · doi:10.1111/acel.70307 · Cited by 2
Cellular senescence in lung cancer immune microenvironment and senotherapeutic opportunities
Xu, Z., Liu, F., Huang, S., & Chu, Q. (2026) · iScience · doi:10.1016/j.isci.2026.114673 · Cited by 4
Oncolytic Probiotics with Molecular Pili for Solid Tumor Therapy
Ge, H., Ding, C., Yang, X., Gao, S., Yang, C., Hou, Y., Wang, H., Bian, L., Zhong, H., Qu, Y., et al. (2026) · Advanced Science · doi:10.1002/advs.202517989 · Cited by 2
Conquering aging-related immunosenescence and tumor immune escape
Zhang, S., Yang, B., Xu, M., 邴英, Zhang, J., Wang, Y. L., Zheng, C., Zhang, G., & Zhang, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1785351 · Cited by 2
Epigenetic dynamics of cellular senescence: From mechanistic insights to precision senotherapy
Hu, X., Lai, W., Liu, M., & Wang, B. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004042 · Cited by 2
Cellular senescence in cancer immunology and potential therapeutic strategy
Qian, X., Tao, L., Zhang, L., Ji, A., Wang, L., Iqbal, M. M., & Luo, Y. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1737652 · Cited by 3
Molecular mechanisms and recent advances in cellular senescence
Hussain, A., Tatar, M., & Gong, R. (2026) · Cell & Bioscience · doi:10.1186/s13578-026-01596-x · Cited by 2
ZNF512B safeguards genome integrity at regulatory regions to repress the SASP and inflammation
Sahu, S. K., Memczak, S., Thakurela, S., Lu, J., Gupta, P., Mutukula, N., Hirano, A., Zhang, Y., Hishida, T., Kurita, M., et al. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.05.009 · Cited by 2
Immune surveillance and immune evasion of senescent cells
Garcia-Baucells, P., Serrano, M., & Amor, C. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01335-w · Cited by 4
Wang, Y., Sun, M., Zhang, T., Feng, Y., Luo, X., Xie, M., Ji, X., Liu, D., Huang, W., & Xia, L. (2022) · Oncology and Translational Medicine · doi:10.1007/s10330-022-0556-6 · Cited by 2
Lin, T., Wang, H., Liu, Y., Zhao, F., & He, X. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1176292 · Cited by 3
A Platinum‐Aluminum Bimetallic Salen Complex for Pro‐senescence Cancer Therapy
Tang, J., Yang, Y., Yin, H., Ma, B., Zhu, M., Yang, Z., Peng, X., Jia, F., Zhao, Y., Wang, F., et al. (2024) · ChemBioChem · doi:10.1002/cbic.202400105 · Cited by 2
Yazdani, A. N., Pletsch, M. C., Chorbajian, A., Zitser, D., & Rai, V. (2024) · Biocell · doi:10.32604/biocell.2024.056252 · Cited by 2
Arachidonoylethanolamide promotes cellular senescence in a human glioblastoma cell line
Zapi-Colín, L. Á., Dotor-Hernández, J. E., Contreras, I., & Estrada, J. A. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.151235 · Cited by 2
Deng, X., Zhang, H., Wang, Y., Ma, D., & Wu, Q. (2025) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.4c00469 · Cited by 2
Current Methodologies to Assess Cellular Senescence in Cancer
Laouris, P., & Muñoz‐Espín, D. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4426-3_2 · Cited by 2
Gao, X., Shen, X., Huang, S., & Huang, S. (2025) · Discover Oncology · doi:10.1007/s12672-025-02127-9 · Cited by 3
Prp19 Facilitated p21-Dependent Senescence of Hepatocellular Carcinoma Cells
Yin, J., Zhang, G., Fang, Y., Yu, X., Liu, T., Dong, L., & Shen, X. (2022) · Journal of Oncology · doi:10.1155/2022/5705896 · Cited by 2
RetractedJiang, Y., Luo, K., Xu, J., Shen, X., Gao, Y., Fu, W., Zhang, X., Wang, H., & Liu, B. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.912537 · Cited by 2
Zhong, F., Yang, Y., Yao, F., Liu, J. L., Yu, X., Wang, X., Huang, B., & Wang, X. (2023) · Aging · doi:10.18632/aging.205123 · Cited by 2
Self-citation
Metadata
- Authors
- Eggert, T., Wolter, K., Ji, J., Ma, C., Yevsa, T., Klotz, S., Medina-Echeverz, J., Longerich, T., Forgues, M., Reisinger, F., Heikenwalder, M., Wang, X. W., Zender, L., & Greten, T. F.
- Affiliations
- National Institutes of Health (US)
- University of Tübingen (DE)
- Universitätsklinikum Aachen (DE)
- German Cancer Research Center (DE)
- Corresponding author
- Zender, Lars
- Greten, Tim F.
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 30
- Issue
- 4
- Pages
- 533-547
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC7789819
- OpenAlex
- W2530995434
- Semantic Scholar
- 45e8e4d91cc1db28efeb781d9d19abda9935ae32
- Cited by
- 609
- References
- 40
- Citations by year
- 2026: 50 · 2025: 68 · 2024: 86 · 2023: 71 · 2022: 76 · 2021: 75 · 2020: 66 · 2019: 41 · 2018: 44 · 2017: 31 · 2016: 1
- FWCI
- 23.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Site cant be reached (submittedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- DFG (FOR2314, SFB685)
- Gottfried Wilhelm Leibniz Program
- European Research Council
- German Ministry for Education and Research
- German Universities Excellence Initiative
- German Center for Translational Cancer Research
- German-Israeli Cooperation in Cancer Research
- Stiftung Experimentelle Biomedizin
- Pre-clinical Comprehensive Center
- Helmholtz foundation
- NIH
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- oncogene-induced senescence, hepatocellular carcinoma, CCR2, myeloid cell recruitment, chemokines, NK cell inhibition, tumor progression, tumor initiation
- MeSH terms
- Animals, Female, Carcinoma, Hepatocellular, Humans, Immunologic Surveillance, Liver Neoplasms, Mice, Inbred BALB C, Mice, Inbred C57BL, Cellular Senescence, Mice, Knockout, Disease Progression, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
